𝔖 Bobbio Scriptorium

✦ LIBER ✦

A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection

✍ Scribed by Marcella Visentini; Serena Ludovisi; Antonio Petrarca; Federica Pulvirenti; Marco Zaramella; Monica Monti; Valentina Conti; Jessica Ranieri; Stefania Colantuono; Elisa Fognani; Alessia Piluso; Carmine Tinelli; Anna Linda Zignego; Mario U. Mondelli; Massimo Fiorilli; Milvia Casato

Book ID: 113482459
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 333 KB
Volume: 10
Category: Article
ISSN: 1568-9972
DOI: 10.1016/j.autrev.2011.04.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II randomized, double-blind, pla

A phase II randomized, double-blind, placebo-controlled multicenter study of recombinant human interleukin-12 for the treatment of chronic hepatitis C virus infection in patients non-responsive to previous treatment with interferon-alpha with or without ribavirin: Paul J Pockros, John G McHutchison, Scripps Clinic, La Jolla, CA; Chris O'Brien, University of Miami, Miami, FL; Myron Tong, Huntingon Medical Research Institute, Pasadena, CA; Coleman Smith, Minnesota Clinical Research Center, St. Paul, MN; Vinod Rustgi, Metropolitan Research Group, Fairfax, VA; Robert L Carithers, University of Washington Medical Center, Seattle, WA; Elizabeth Olek, Genetics Institute, Cambridge, MA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB